Section Arrow
GLYC.NASDAQ
- GlycoMimetics
Quotes are at least 15-min delayed:2024/05/19 06:06 EDT
Last
 0.2994
+0.0183 (+6.51%)
Day High 
0.31 
Prev. Close
0.2811 
1-M High
2.39 
Volume 
2.71M 
Bid
0.2907
Ask
0.304
Day Low
0.283 
Open
0.283 
1-M Low
0.256 
Market Cap 
18.12M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.44 
20-SMA 1.09 
50-SMA 2.05 
52-W High 3.38 
52-W Low 0.256 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.58/-0.15
Enterprise Value
18.19M
Balance Sheet
Book Value Per Share
0.45
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals0.1186-0.0014-1.17%-- 
SCPXScorpius Holdings0.1035+0.0034+3.40%-- 
JAGXJaguar Health0.2585-0.0282-9.84%-- 
DNAGinkgo Bioworks Holdings0.8056-0.0334-3.98%-- 
ONCOOnconetix0.156+0.015+10.64%-- 
Quotes are at least 15-min delayed:2024/05/19 06:06 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.